2025 HCPCS Code Q5124
Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg
| Short Description | Inj. byooviz, 0.1 mg |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | April 01, 2022 |
| HCPCS Action Effective Date | January 01, 2023 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q4328 - Most, per sq cm
- Q4329 - Singlay, per sq cm
- Q4330 - Total, per sq cm
- Q4331 - Axolotl graft, per sq cm
- Q4332 - Axolotl dualgraft, per sq cm
- Q4333 - Ardeograft, per sq cm
- Q5001 - Hospice or home hlth in home
- Q5002 - Hospice/home hlth in asst lv
- Q5003 - Hospice in lt/non-skilled nf
- Q5004 - Hospice in snf
- Q5005 - Hospice, inpatient hospital
- Q5006 - Hospice in hospice facility
- Q5007 - Hospice in ltch
- Q5008 - Hospice in inpatient psych
- Q5009 - Hospice/home hlth, place nos
- Q5010 - Hospice home care in hospice
- Q5101 - Injection, zarxio
- Q5102 - Inj., infliximab biosimilar
- Q5103 - Injection, inflectra
- Q5104 - Injection, renflexis